Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Other Non Operating Income (2017 - 2025)

Historic Other Non Operating Income for Rockwell Medical (RMTI) over the last 9 years, with Q3 2025 value amounting to -$169000.0.

  • Rockwell Medical's Other Non Operating Income rose 3786.76% to -$169000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$704000.0, marking a year-over-year increase of 6123.35%. This contributed to the annual value of -$1.1 million for FY2024, which is 3849.63% up from last year.
  • Rockwell Medical's Other Non Operating Income amounted to -$169000.0 in Q3 2025, which was up 3786.76% from -$143000.0 recorded in Q2 2025.
  • Rockwell Medical's 5-year Other Non Operating Income high stood at -$135000.0 for Q3 2023, and its period low was -$965000.0 during Q4 2023.
  • For the 5-year period, Rockwell Medical's Other Non Operating Income averaged around -$397947.4, with its median value being -$396000.0 (2022).
  • As far as peak fluctuations go, Rockwell Medical's Other Non Operating Income plummeted by 90281.69% in 2021, and later soared by 7544.04% in 2024.
  • Quarter analysis of 5 years shows Rockwell Medical's Other Non Operating Income stood at -$582000.0 in 2021, then surged by 31.96% to -$396000.0 in 2022, then crashed by 143.69% to -$965000.0 in 2023, then surged by 75.44% to -$237000.0 in 2024, then increased by 28.69% to -$169000.0 in 2025.
  • Its Other Non Operating Income stands at -$169000.0 for Q3 2025, versus -$143000.0 for Q2 2025 and -$155000.0 for Q1 2025.